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Abstract 
Thoraco-abdominal aneurysms (TAAA) represents a particularly lethal vascular disease that 
without surgical repair carries a dismal prognosis. However, there is an inherent risk from 
surgical repair of spinal cord ischaemia that can result in paraplegia. One method of reducing 
this risk is cerebrospinal fluid (CSF) drainage. We believe that the CSF contains clinically 
significant biomarkers that can indicate impending spinal cord ischaemia. This work 
therefore presents a novel measurement method for proteins, namely albumin, as a precursor 
to further work in this area.  The work uses an interdigitated electrode (IDE) sensor and 
shows that it is capable of detecting various concentrations of albumin (from 0 to 100 g/L) 
with a high degree of repeatability at 200 MHz (R
2
 = 0.991) and 4 GHz (R
2
 = 0.975). 
 
Introduction 
Thoraco-abdominal aneurysms (TAAA) represent a particularly lethal vascular disease, 
resulting from the continuous dilation of any part of the descending aorta from the left 
subclavian artery to the bifurcation of the aorta into the iliac branches in the abdomen. 
Ultimately, the natural history of any aortic aneurysm is the inherent risk of dissection or 
rupture. Without treatment TAAAs are associated with a particularly dismal prognosis, with 5 
year survival in non-operated patients as low as 10% [1-3].  
Elective surgical repair for TAAAs, when successful can provide survival rates that are 
comparable to that of the general population [4]. However, TAAA open surgical or 
endovascular aneurysm repair (EVAR) is major extensive surgery and carries a significant 
risk of mortality and post-operative complications of which the most feared and devastating 
is that of paraplegia. This is a direct consequence of the restriction of spinal cord blood flow 
during surgical repair and consequently causes spinal cord ischaemia (SCI) [5]. Published 
rates of spinal cord ischaemia are varied worldwide can have been reported as high as 30% 
[6-10].  
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Over the past half century numerous adjuncts to reduce the risk of SCI have been developed 
and are routinely employed to provide neuro-protection through the maintenance of adequate 
perfusion to the spinal cord. These methods include: 
 Deep hypothermic circulatory arrest which decreases the body’s metabolic activity 
and oxygen demand [11-13] . 
 Motor-evoked potentials (MEP) which is able to provide near real time assessment of 
spinal cord function intraoperatively through stimulating the motor cortex and 
recording any subsequent muscle action potentials and potentially alert the surgeon of 
impending SCI [14-16] . 
 Sequential clamping and reattachment of patent intercostal arteries to the graft 
inserted onto the aorta which directly supply the spinal cord with blood [17]. 
 Cerebrospinal fluid drainage (CSFD) which has a strong evidence basis underpinning 
its use, reducing the pressure of cerebrospinal fluid (CSF) surrounding the spinal cord 
and consequently increases spinal cord perfusion [2, 18-19] . 
Researchers at Liverpool Heart and Chest Hospital and Liverpool John Moores University 
believe that the drained CSF may harbour clinically important information that can provide 
indications to SCI. With this in mind the authors are developing a sensor that can detect in 
real time changes in clinically relevant biomarkers in the CSF that correlate to impending 
spinal cord ischaemia and hence providing a tool that alerts the surgeon to intervene.  
Our current research is evolving around developing a sensor that utilises electromagnetic 
(EM) waves, particularly microwaves. The authors have already demonstrated the ability of 
this technology to detect various substances including, glucose at physiological levels, 
lactate, and oils [20-24]. Furthermore, they have demonstrated the possibility to detect lactate 
in water, phosphate buffered solution, and CSF. Lactate is commonly used as a marker of 
tissue hypoxia and hence lactate CSF levels have previously been researched with respects to 
its correlation to spinal cord ischaemia. However, although there is a good correlation to 
spinal cord ischaemia and rises in CSF lactate, there is a lag between its rise and development 
of CSF lactate [25]. There is now considerable interest with respects to specific biomarkers 
that can be biochemically analysed and are more sensitive to spinal cord ischaemia than 
lactate [26-31].  In particular, interest has arisen in the area of protein level monitoring, and 
so the aim of this work is to determine the ability of EM wave sensors to measure varying 
quantities of protein. 
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Methods 
Sample preparation  
Bovine serum albumin (A2153, Sigma-Aldrich) was hydrated using deionised water.  
Dilutions, in g/L, were made as follows: 0, 1, 10, 40 and 100.  The samples were prepared 
and measured in the same day, with a short period allowed for them to acclimatise to room 
temperature prior to measurement.   
Acquisition measurements  
Measurement was performed using a ZVA-24 Rohde and Schwarz Vector Network Analyser 
(VNA). The instrument can generate and measure frequencies up to 24GHz, although for this 
experimental procedure 15GHz was the maximum frequency attained due to the limitation of 
the type of connector used on the sensor itself.  
Figure 1 depicts the experimental set up with an interdigitated electrode (IDE) connected to 
the VNA. Initially we found that the sensor is extremely sensitive to both temperature and 
volume. Therefore, all samples were allowed to confluence to room temperature and repeated 
measurements (n=10) were taken in quick succession for all dilutions to establish 
repeatability. 
  
(a) (b) 
Figure 1. Illustrating (a) the Rohde and Schwarz VNA equipment used for measurement and 
(b) the sensor used for the experimental work. 
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The IDE sensor was fabricated using a industrial standard chemical etching method, with the 
patterned electrode being on a Rogers substrate and gold plated to prevent sensor degradation 
due to interaction with samples.  The design of the IDE allows measurement of the reflected 
power from the sensor via the S11 parameter.  It accommodates a 400µL fluid sample due to a 
well which is bonded to the structure, and the sample is introduced via a pipette.   
The VNA was permitted to scan through all frequencies (10MHz to 15 GHz) at least 3 times 
before a recording was made, to allow for sensor output stabilisation. Each measurement 
enabled the recording of 60,000 data points in the selected frequency range.  Between 
samples the IDE was washed with distilled water and left to dry before further measurements 
took place.  
Results are analysed and graphs plotted with Origin® 9.1 Data Analysis and Graphing 
Software. 
 
Results 
The results obtained have been processed to remove outliers using an average standard 
deviation (σ) method (i.e. where the mean σ > 2, results were discarded).  This resulted in 
10% of the 50 available measurements being discarded.  Figure 2 illustrates the mean spectra 
captured during the experimental work, with emphasis being given to the frequency range 
between 10 MHz and 6 GHz; beyond these frequencies little change was noted, likely due to 
the design of the sensor not favouring higher frequency excitation.  This figure shows clear 
shifts in the captured signal throughout the displayed spectrum, but this is further highlighted 
in Figure 3, namely at 200 MHz and 4 GHz. 
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 Figure 2. Mean spectra captured during experimental work between 10 MHz and 6 GHz. 
 
(a) 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 (b) 
Figure 3. Illustrating the relationship between albumin concentration and S11 magnitude 
(dBm) for the frequencies (a) 200 MHz and (b) 4 GHz. 
At 200 MHz, the relationship between albumin concentration and S11 magnitude follows an 
approximately linear trend, where R
2
 = 0.991.  A high degree of repeatability is exhibited, 
with σ ≤ 0.008 across all repeated measurements for all dilutions.  When comparing the 
measurements for different dilutions it is noted that σ = 0.386.  This demonstrates that while 
the sensor exhibits very little change between repetitions of the same albumin concentration, 
as the concentration varies, the sensor output changes significantly. 
At 4 GHz an exponential trend is shown.  Here, R
2 
= 0.975, repeatability is characterised by 
σ ≤ 0.259 across all repeated measurements for all dilutions, and when comparing 
measurements for different dilutions σ = 1.591.   
 
Discussion 
Although there are many methods used to try and prevent spinal cord ischaemia, the only 
method of evaluating the integrity of the spinal cord intra-operatively is the use of motor 
evoked potentials (MEPs). However this technology does not have strong evidence 
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underpinning its use. This is reflected in such that worldwide there is no consensus in its use 
and applicability and consequently there is huge variation in how MEP measurements are 
used worldwide [14-16].  
There has been a good amount of research regarding potential detectable biomarkers in the 
CSF and their correlation to spinal cord ischaemia. Drenger et al measured lactate 
concentrations in both CSF and serum during thoracoabdominal aneurysm repair [25]. 
Patients who became paraplegic showed a greater increase in CSF lactate concentrations after 
aortic clamp release compared with those who suffered no neurological damage. 
Furthermore, CSF measurement of lactate decreased with strategies used to protect the spinal 
cord (hypothermia and distal aortic perfusion). These results have been reproduced in a more 
recent study by Casiraghi et al where 4 patients developed SCI, and CSF lactate was 
significantly higher before, during and after surgery [32]. Our previous work has already 
shown the ability of our sensor to accurate measure lactate at physiological levels with our 
sensor with tangible evidence that this could be possible in real time [20-21, 24].  
With time there has been considerable interest of biomarkers that can be biochemically 
analysed in CSF that are more sensitive to SCI than lactate. There has been considerable 
interest in the S100β protein, which is a glial specific protein expressed primarily by 
astrocytes. This protein is secreted in large quantities following the acute phase of brain 
trauma and ischaemia. Khaladj et al studied 13 patients undergoing elective 
thoracoabdominal aneurysm surgery, and of these 2 developed spinal cord injury [29]. In the 
patients that developed spinal cord ischaemia there was a strong correlation between S100β 
and lactate levels in the CSF compared to those who did not. Anderson et al analysed the CSF 
and serum of 11 patients who underwent thoracoabdominal aneurysm surgery and measured 
S100β, lactate, neuronal specific endolase, glial fibrillary acidic protein [30]. One patient 
suffered stroke following surgery, which cause significant rises in all biochemical markers 
measured in the CSF. A further patient who suffer paraplegia again showed significant 
increases in all biomarkers. GFPa in this study was found to increase in patients with 
neurological damage but not in those without. This finding of increases in GFPa was further 
reinenforced by a study from the Safi group where GFAp increased before or in parallel to 
onset of symptoms in the patients with delayed paraplegia [31]. However, although these 
biomarkers show excellent probability for use during TAAA repair they currently require 
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biochemical laboratory analysis which and requires time, expensive equipment and specialist 
expertise, not conductive to a real time sensor which could be used intra-operatively.  
The utilisation of electromagnetic waves, particularly microwaves, has a number of benefits 
which make this suitable for our current area of research. Firstly, microwaves are non-
ionising with a low power output of approximately 1mW (0dBm) making this technology 
safe for use at the bedside for both patient and operator. Furthermore, the data output can be 
produced in real time making this an attractive quality during an operation. We are currently 
able to manufacture these sensors at low cost and believe that this will be reflected in the 
final product which is important in the current economic climate. The multi-parameter nature 
of wide band microwave analysis can provide unique spectrum signatures which yields a vast 
array of data. 
We believe that our current results show that microwave analysis can provide a sufficient 
means of detecting protein over a range of concentrations. Our current experimentation now 
focuses on calibrating our sensor to detection of different types of proteins in different 
substrates including human CSF as well as improving the sensitivity and resolution of the 
sensor. Our current study remains a proof of concept, as although albumin is a protein, it is 
unlikely in itself to be a marker of spinal cord ischemia.  This said however, related work of 
the authors in agriculture has shown albumin to be a valuable measure of long-term protein 
level in livestock and thus could well prove open up a new way to determine the effectiveness 
of diet. 
 
Conclusions 
This work uses an interdigitated electrode (IDE) sensor and shows that it is capable of 
detecting various concentrations of albumin (from 0 to 100 g/L) with a high degree of 
repeatability at 200 MHz (R
2
 = 0.991) and 4 GHz (R
2
 = 0.975).  This work presents a 
significant step toward the measurement of a broad range of proteins, with the aim of being 
able to measure them in real-time in order to enhance the success of TAAA repair 
procedures.  This will be a step-change to current measurement procedures which require 
costly lab-based measurements which are not capable of returning results in a timely fashion.  
Our future experimentation will focus on improving the sensitivity and resolution of the 
sensor, as well as testing it on human CSF samples.  
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